Chemomab Therapeutics Ltd. Earnings Per Share (Basic)
Chemomab Therapeutics Ltd. (CMMB) reported Earnings Per Share (Basic) of $0.02 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-03-23
- Chemomab Therapeutics Ltd. earnings per share, basic for the quarter ending 2024-06-30 was $0.01, a 63.89% decline year-over-year.
- Chemomab Therapeutics Ltd. earnings per share, basic for the quarter ending 2023-06-30 was $0.04, a 33.33% increase year-over-year.
- Chemomab Therapeutics Ltd. earnings per share, basic for the quarter ending 2023-03-31 was $0.04, a 81.82% increase year-over-year.
- Chemomab Therapeutics Ltd. earnings per share, basic for the quarter ending 2022-12-31 was -$0.04.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.02 20-F · filed 2026-03-23 | |||
| 2025-06-30 | $0.01 6-K · filed 2025-08-14 | |||
| 2024-12-31 | $0.04 20-F · filed 2026-03-23 | |||
| 2024-06-30 | $0.01 6-K · filed 2024-08-21 | $0.03 6-K · filed 2025-08-14 | ||
| 2023-12-31 | $0.10 20-F · filed 2026-03-23 | |||
| 2023-06-30 | $0.04 6-K · filed 2024-08-21 | $0.08 6-K · filed 2024-08-21 | -$0.11 derived: net income ÷ weighted average shares · filed 2025-04-04 | -$0.15 derived: net income ÷ weighted average shares · filed 2025-04-04 |
| 2023-03-31 | $0.04 10-Q · filed 2023-05-11 | -$0.08 derived: net income ÷ weighted average shares · filed 2025-04-04 | -$0.11 derived: net income ÷ weighted average shares · filed 2025-04-04 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-04-04 |
| 2022-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2025-04-04 | -$0.07 derived: net income ÷ weighted average shares · filed 2025-04-04 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-04-04 | $0.12 20-F · filed 2025-04-04 |
| 2022-09-30 | $0.04 10-Q · filed 2022-11-10 | -$0.06 derived: net income ÷ weighted average shares · filed 2023-08-14 | $0.09 10-Q · filed 2022-11-10 | -$0.11 derived: net income ÷ weighted average shares · filed 2024-03-28 |
| 2022-06-30 | $0.03 6-K · filed 2023-08-14 | $0.05 6-K · filed 2023-08-14 | -$0.07 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.08 derived: net income ÷ weighted average shares · filed 2024-03-28 |
| 2022-03-31 | $0.02 10-Q · filed 2023-05-11 | -$0.04 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.06 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.07 derived: net income ÷ weighted average shares · filed 2024-03-28 |
| 2021-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.03 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.05 derived: net income ÷ weighted average shares · filed 2024-03-28 | $0.06 20-F · filed 2024-03-28 |
| 2021-09-30 | $0.01 10-Q · filed 2022-11-10 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-11-10 | $0.04 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $0.01 10-Q · filed 2022-08-12 | $0.02 10-Q · filed 2022-08-12 |